within Pharmacolibrary.Drugs.ATC.L;

model L04AH01
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.15,
    Cl             = 3.6e-05,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.012,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0002666666666666667,
    Tlag           = 600,            
    Vdp             = 0.175,
    k12             = 36.3,
    k21             = 36.3
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L04AH01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Sirolimus is an immunosuppressive drug primarily used to prevent rejection in organ transplantation, particularly kidney transplants. It is an mTOR inhibitor and also has antiproliferative and antifungal properties. It is approved and widely used today.</p><h4>Pharmacokinetics</h4><p>Reported pharmacokinetics in healthy adult volunteers following single oral dose administration.</p><h4>References</h4><ol><li><p>Kirchner, GI, et al., &amp; Manns, MP (2004). Clinical pharmacokinetics of everolimus. <i>Clinical pharmacokinetics</i> 43(2) 83–95. DOI:<a href=\"https://doi.org/10.2165/00003088-200443020-00002\">10.2165/00003088-200443020-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14748618/\">https://pubmed.ncbi.nlm.nih.gov/14748618</a></p></li><li><p>Adams, DM, et al., &amp; Azizkhan, RG (2016). Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies. <i>Pediatrics</i> 137(2) e20153257–None. DOI:<a href=\"https://doi.org/10.1542/peds.2015-3257\">10.1542/peds.2015-3257</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26783326/\">https://pubmed.ncbi.nlm.nih.gov/26783326</a></p></li><li><p>Lee, KJ, et al., &amp; Chaturvedi, RR (2015). Pharmacokinetics of sirolimus-eluting stents implanted in the neonatal arterial duct. <i>Circulation. Cardiovascular interventions</i> 8(5) –. DOI:<a href=\"https://doi.org/10.1161/CIRCINTERVENTIONS.114.002233\">10.1161/CIRCINTERVENTIONS.114.002233</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25940522/\">https://pubmed.ncbi.nlm.nih.gov/25940522</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L04AH01;
